Del Paggio JC. Cancer immunotherapy and the value of cure. Nat Rev Clin Oncol. 2018;15:268-270. doi: 10.1038/nrclinonc.2018.27   Huang AC, Zappasodi R. A decade of checkpoint blockade immunotherapy in melanoma: Understanding the molecular basis for immune sensitivity and resistance. Nat Immunol. 2022;23:660-670. doi: 10.1038/s41590-022-01141-1   Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473. doi: 10.1126/science.aaw5473   Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141-162. doi: 10.1038/s41573-021-00339-6   Goga A, Stoffel M. Therapeutic RNA-silencing oligonucleotides in metabolic diseases. Nat Rev Drug Discov. 2022;21:417-439. doi: 10.1038/s41573-022-00407-5   Ji S, Jiang B, Hao H, et al. Matching the kinetics of natural enzymes with a single-atom iron nanozyme. Nat Catal. 2021;4:407-417. doi: 10.1038/s41929-021-00609-x   Zhang R, Jiang B, Fan K, Gao L, Yan X. Designing nanozymes for in vivo applications. Nat Biomed Eng. 2024;2:849-868. doi: 10.1038/s44222-024-00205-1   Hu X, Zhang B, Zhang M, et al. An artificial metabzyme for tumour-cell-specific metabolic therapy. Nat Nanotechnol. 2024;19:1712-1722. doi: 10.1038/s41565-024-01733-y